Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells

References

• Adamson DC, McArthur JC, Dawson TM, Dawson VL (1999). Rate and severity of HIV-associated dementia (HAD): Correlations with Gp41 and iNOS. Mol Med 5: 98–109.
   Google Scholar
• Adamson DC, Wildemann B, Sasak MI, Glass JD, Mcarthur JC, Christov VI, Dawson TM, Dawson VL (1996). Im-munologic NO synthase: Elevation in severe AIDS de-mentia and induction by HIV-1 gp41. Science 274: 1917–1921.
   Google Scholar
• Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995). Glutamate- induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neu-ron 15: 961–973.
   Google Scholar
• Bains JS, Shaw CA (1997). Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 25: 335–358.
   PubMed Web of Science ®Google Scholar
• Beary TP, Tencza SB, Mietzner TA, Montelaro RC (1998). Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein. I Peptide Res 51: 75–79.
   Google Scholar
• Castagna A, Le Grazie C, Accordini A, Giulidori P, Cavalli G, Bottiglieri T, Lazzarin A (1995). Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concen-trations in HIV infection: Effect of parenteral treatment with SAMe. Neurology 45: 1678–1683.
   PubMed Web of Science ®Google Scholar
• Chernomordik L, Chanturiya A, Suss-Toby E, Nora E, Zimmerburg J (1994). An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in mem-branes. I Virol 68: 7115–7123.
   PubMed Web of Science ®Google Scholar
• Choi J, Liu RM, Kundu RK, Sangiorgi F, Wu W, Maxson R, Forman HJ (2000). Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. I Biol Chem 275: 3693–3698.
   Google Scholar
• Chong YH, Lee MJ (2000). Expression of complement in-hibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides. I NeuroVirol 6: 51–60.
   PubMed Web of Science ®Google Scholar
• Comardelle AM, Norris CH, Plymale DR, Gatti PJ, Choi B, Fermin CD, Haislip AM, Tencza SB, Mietzner TA, Montelaro RC, Garry RF (1997). A synthetic peptide cor-responding to the carboxy terminus of human immun-odeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xeno-pus laevis oocytes. AIDS Res Hum Retro 13: 1525–1532.
   Google Scholar
• Cooper JJL (1997). Glutathione in the brain: Disorders of glutathione metabolism. In: The molecular and genetic basis of neurological disease. Barchi RL, Kunk LM (eds). Butterworth-Heinemann: Boston, pp 1195–1230.
   Google Scholar
• Cossarizza A, Mussini C, Mongiardo N, Borghi V, Sabbatini A, De Rienzo B, Franceschi C (1996). Mitochondrial al-terations and a dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syn-drome. AIDS 11: 19–26.
   Google Scholar
• Coyle JT, Puttfarcken P (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689–695.
   PubMed Web of Science ®Google Scholar
• Droge W (1993). Cysteine and glutathione deficiency in AIDS patients: A rationale for the treatment with N-acetylcysteine. Pharmacology 46: 61–65.
   PubMed Web of Science ®Google Scholar
• Fermin CD, Garry RF (1992). Membrane alterations linked to early interactions of HIV with the cell surface. Virol-ogy 191: 941–946.
   Google Scholar
• Fernândez-Checa JC, Kaplowitz N (1990). The use of monochlorobimane to determine hepatic GSH levels and synthesis. Anal Biochem 190: 212–219.
   PubMed Web of Science ®Google Scholar
• Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, Richman DD, Carson DA, Corbeil J, Leoni LM (2001). HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB 15: 5–6.
   Google Scholar
• Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Im-munocytochemic al quantitation of human immunode-ficiency virus in the brain: Correlations with dementia. Ann Neurol 38: 755–762.
   PubMed Web of Science ®Google Scholar
• Glass JD, Johnson RT (1996). Human immunodeficiency virus and the brain. Annu Rev Neurosci 19: 1–26.
   PubMed Web of Science ®Google Scholar
• Haraguchi S, Good RA, Day NK (1995). Immunosuppres-sive retroviral peptides: cAMP and cytokine patterns. Immunol Today 16: 595–603.
   PubMedGoogle Scholar
• Helbling B, von Overbeck J, Lauterburg BH (1996). De-creased release of glutathione into the systemic circu-lation of patients with HIV infection. Eur I Clin Invest 26: 38–44.
   Google Scholar
• Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA (1997). Glutathione deficiency is associated with im-paired survival in HIV disease. Proc Natl Acad Sci USA 94: 1967–1972.
   PubMed Web of Science ®Google Scholar
• Hoyt KR, Gallagher AJ, Hastings TG, Reynolds IJ (1997). Characterization of hydrogen peroxide toxicity in cul-tured rat forebrain neurons. Neurochem Res 22: 333–340.
   Google Scholar
• Jain A, Martensson J, Stole E, Auld PA, Meister A (1991). Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA 88: 1913–1917.
   Google Scholar
• Ju C, Yoon KN, Oh YK, Kim HC, Shin CY, Ryu JR, Ko KH, Kim WK (2000). Synergistic depletion of astrocytic glutathione by glucose deprivation and peroxynitrite: Correlation with mitochondrial dysfunction and subse-quent cell death. J Neurochem 74: 1989–1998.
   Google Scholar
• Kalebic T, Masiero L, Onisto M, Garbisa S (1994). HIV-1 modulates the expression of gelatinase A and B in mono-cyic cells. Biochem Biophy Res Commun 205: 1243–1249.
   PubMedGoogle Scholar
• Kort JJ (1998). Impairment of excitatory amino acid trans-port in astroglial cells infected with the human immu-nodeficiency virus type 1. AIDS Res Hum Retro 14: 1329–1339.
   Google Scholar
• Kroemer G, Dallaporta B, Resche-Rigion M (1998). The mi-tochondrial death/life regulator in apoptosis and necro-sis. Annu Rev Physiol 60: 619–642.
   Google Scholar
• Kroemer G, Reed JC (2000). Mitochondrial control of cell death. Nat Med 6: 513–519.
   PubMed Web of Science ®Google Scholar
• Macho A, Castedo M, Marchetti P, Aguilar JJ, Decaudin D, Zamzami N, Girard PM, Uriel J, Kroemer G (1995). Mi-tochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood 86: 2481–2487.
   PubMed Web of Science ®Google Scholar
• Marschang P, Kruger U, Ochsenbauer C, Gurtler L, Hittmair A, Bosch V, Patsch JR, Dierich MP (1997). Complement activation by HIV-1 infected cells: The role of trans-membrane glycoprotein gp41. I AIDS Hum Retrovirol 14: 102–109.
   PubMedGoogle Scholar
• Masliah E, Achim CL, Ge N, Eeteresa RD, Terry RD, Wiley CA (1992). Spectrum of human immunodefi-ciency virus-ass ociated ne oc ortic al damage. Ann Neurol 32: 321–329.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Culmsee C, Yu Z, Camandola S (2000). Roles of nuclear factor KB in neuronal survival and plasticity. J Neurochem 74: 443–456.
   PubMed Web of Science ®Google Scholar
• Miller MA, Cloyd MW, Liebmann J, Rinaldo C, Islam KR Jr, Wang SZ, Mietzner TA, Montelaro RC (1993a). Alter-ations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196: 89–100.
   Google Scholar
• Miller MA, Garry RF, Jaynes JM, Montelaro RC (1991). A structural correlation between lentivirus transmem-brane proteins and natural cytolytic peptides. AIDS Res Hum Retro 7: 511–519.
   PubMed Web of Science ®Google Scholar
• Miller MA, Mietzner TA, Cloyd MW, Robey WG, Montelaro RC (1993b). Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res Hum Retro 9: 1057–1066.
   PubMedGoogle Scholar
• Millis KK, Lesko SA, Gamcsik MP (1997). Formation, in-tracellular distribution and efflux of glutathione-bimane conjugates in drug-sensitive and -resistant MCF-7 cells. Cancer Chemother Pharmacol 40: 101–111.
   Google Scholar
• Nuydens R, Novalbos J, Dispersyn G, Weber C, Borgers M, Geerts H (1999). A rapid method for the evaluation of compounds with mitochondria-protective properties. I Neurosci Methods 92: 153–159.
   PubMed Web of Science ®Google Scholar
• Plymale DR, Comardelle AM, Fermin CD, Martin DS, Costin JM, Norris CH, Tencza SB, Mietzner TA, Montelaro RC, Garry RF (1999a). Concentration-dependent differential induction of necrosis or apop-tosis by HIV-1 lytic peptide 1. Peptides 20: 1275–1283.
   Google Scholar
• Plymale DR, Ng Tang DS, Comardelle AM, Fermin CD, Martin DS, Lewis DE, Garry RF (1999b). Both necro-sis and apoptosis contribute to HIV-1-induced killing of CD4 cells. AIDS 13: 1827–1839.
   Google Scholar
• Reers M, Smith TW, Chen LB (1991). J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30: 4480–4486.
   PubMed Web of Science ®Google Scholar
• Rostasy K, Monti L, Yiannoutsos C, Kneissl M, Bell J, Kemper TL, Hedreen JC, Navia BA (1999). Human im-munodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Patho-genetic relationship to the acquired immunodeficiency syndrome dementia complex. Ann Neurol 46: 207–216.
   PubMed Web of Science ®Google Scholar
• Ruegg CL, Strand MA (1991). Synthetic peptide with se-quence identity to the transmembrane protein Gp41 of HIV-1 inhibits distinct lymphocytes activation path-ways dependent on protein kinase C and intracellular calcium influx. Cell Immunol 137: 1–13.
   Google Scholar
• Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A (1997). JC-1, but not Di0C6(3) or rhodamine 123, is a reliable flu-orescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411: 77–82.
   PubMed Web of Science ®Google Scholar
• Schuchmann S, Heinemann U (2000). Diminished glu-tathione levels cause spontaneous and mitochondria-mediated cell death in neurons from trisomy 16 mice: A model of Down's syndrome. I Neurochem 74: 1205–1214.
   Google Scholar
• Srinivas S, Srinivas R, Anantharamaiah G, Segrest J, Compans R, Segrest J (1993). Cytosolic domain of the
   Google Scholar
• HIV envelope glycoprotein binds to calmodulin and in-hibits calmodulin-regulated proteins. I Biol Chem 268: 22895–22899.
   Google Scholar
• Staal FJ, Ela SW, Roeder M, Anderson MT, Herzenberg LA, Herzenberg LA (1992). Glutathione deficiency and human immunodeficiency virus infection. Lancet 339: 909–912.
   PubMed Web of Science ®Google Scholar
• Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ (1996). T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils re-leases potent chemoattractants for human T lympho-cytes both in vitro and in vivo. I Clin Invest 97: 931–1941.
   Google Scholar
• Tencza S, Miller M, Islam K, Mietzner T, Montelaro RC (1995). Effect of amino acid substitutions on calcodulin binding and cytolytic properties of the LLP-1 peptide segment of HIV-1 transmembrane protein. I Virol 69: 5199–5202.
   Google Scholar
• van der Ven AJ, Blom HJ, Peters W, Jacobs LE, Verver TJ, Koopmans PP, Demacker P, van der Meer JW (1998). Glu-tathione homeostasis is disturbed in CD4-positive lym-phocytes of HIV-seropositive individuals. Eur I Clinic Invest 28: 187–193.
   Google Scholar
• Westendorp MO, Shatrov VA, Schulze-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Droge W, Lehmann V (1995). HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO 114: 546–554.
   Google Scholar
• Zamzami N, Hirsch T, Dallaporta B, Petit PX, Kroemer G (1997). Mitochondrial implication in accidental and programmed cell death: Apoptosis and necrosis. J Bioen-erg Biomembr 29: 185–193.
   PubMed Web of Science ®Google Scholar
• Zasloff M, Martin B, Chen HC (1988). Antimicrobial activity of synthetic magainin peptides and sev-eral analogues. Proc Natl Acad Sci USA 85: 910–913.
   PubMed Web of Science ®Google Scholar